IN BRIEF: Diaceutics says Non-Executive Chair Deborah Davis resigns

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to ...

Alliance News 23 July, 2024 | 7:54PM
Email Form Facebook Twitter LinkedIn RSS

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Says that Non-Executive Chair Deborah Davis intends to step down from the board, effective October 1. Peter Keeling, a co-founder and executive director of Diaceutics, will succeed Davis in the role from the date of her departure.

Chief Executive Officer Ryan Keeling says: "I would like to thank Deborah for her tireless dedication and efforts in guiding Diaceutics through a crucial stage in our development and growth as a public company. We will miss her presence and wish her well for her current and future roles. I look forward to working closely with the board and continuing my close partnership with Peter in his new capacity as chair."

Current stock price: 130.12 pence

12-month change: up 49%

By Holly Beveridge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Diaceutics PLC 131.00 GBX -2.24 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures